VALLEY NATIONAL ADVISERS INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$2,000
-33.3%
1,5050.0%0.00%
-100.0%
Q2 2022$3,0000.0%1,5050.0%0.00%0.0%
Q1 2022$3,000
-25.0%
1,5050.0%0.00%0.0%
Q4 2021$4,000
-42.9%
1,5050.0%0.00%0.0%
Q3 2021$7,000
+133.3%
1,505
+198.0%
0.00%0.0%
Q2 2021$3,000
-25.0%
5050.0%0.00%0.0%
Q1 2021$4,000
+100.0%
5050.0%0.00%
Q4 2020$2,000
-33.3%
5050.0%0.00%
-100.0%
Q3 2020$3,0000.0%5050.0%0.00%0.0%
Q2 2020$3,0000.0%5050.0%0.00%0.0%
Q1 2020$3,000
-40.0%
5050.0%0.00%0.0%
Q4 2019$5,000
+150.0%
5050.0%0.00%0.0%
Q3 2019$2,0005050.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 407,416$14,259,560,0008.34%
Palo Alto Investors LP 3,547,719$124,170,0006.91%
Antipodean Advisors LLC 1,268,658$44,403,0006.48%
Redmile Group, LLC 1,795,936$62,858,0004.70%
HealthCor Management, L.P. 1,525,000$53,375,0003.24%
PointState Capital LP 3,503,900$122,637,0003.12%
NEA Management Company, LLC 1,139,890$39,896,0002.54%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 612,500$21,438,0002.44%
PFM Health Sciences, LP 2,078,440$72,745,0002.21%
Partner Investment Management, L.P. 35,300$1,236,0002.03%
View complete list of CLOVIS ONCOLOGY INC shareholders